BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 (BIOTU)

CUSIP: G1125A124

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / UNIT 11/30/2027
Total 13F shares
6,523,737
Share change
-5,244,728
Total reported value
$65,771,000
Price per share
$10.08
Number of holders
41
Value change
-$51,887,650
Number of buys
10
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP G1125A124?
CUSIP G1125A124 identifies BIOTU - BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 (BIOTU) as of Q2 2021

As of 30 Jun 2021, BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 (BIOTU) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,523,737 shares. The largest 10 holders included ARISTEIA CAPITAL LLC, HGC Investment Management Inc., GLAZER CAPITAL, LLC, Sage Rock Capital Management LP, Magnetar Financial LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, Context Capital Management, LLC, Arena Capital Advisors, LLC- CA, PICTON MAHONEY ASSET MANAGEMENT, and JPMORGAN CHASE & CO. This page lists 41 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.